NCT05484713

Brief Summary

• The aim of 3DP-FAST study is to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure. By conducting a comparative analysis of measurements achieved on CCTA images versus measurements obtained with a specialized projection platform by photogrammetry vs 3D printed models of various aortic valvular and perivalvular structures will be evaluated the accuracy of each step of image dataset processing. Furthermore, the study will evaluate the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block based on coronary computed tomography angiographic and ECG assessment at 1 year after enrollment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 8, 2022

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

July 30, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 2, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

May 16, 2023

Status Verified

July 1, 2022

Enrollment Period

12 months

First QC Date

July 30, 2022

Last Update Submit

May 14, 2023

Conditions

Keywords

aortic stenosis3D printinginterventional planningcardiovascular modelsTAVIAccuracy

Outcome Measures

Primary Outcomes (2)

  • Feasibility of 3D printed models of aortic valves in guiding TAVI procedure

    Analysis of the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure.

    at baseline

  • Rate of complications during 12 months follow-up of patients undergoing TAVI for aortic stenosis

    Re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block during a 12 months follow-up after TAVI procedure.

    12 months

Interventions

Cardiac imagingDIAGNOSTIC_TEST

Baseline - 2D transthoracic echocardiography, 128-multislice CT coronary angiography, CCTA of peripheral lower limbs vessels 12-months follow-up - 128-multislice CT coronary angiography with transthoracic echocardiography

3D printing of the aortic valve based on CCTA image acquisition

Eligibility Criteria

Age60 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a minimum age of 60 years old, with severe degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs, and who do not require the criteria for surgical aortic valve replacement.

You may qualify if:

  • patients with degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs.

You may not qualify if:

  • contraindications for TAVI procedures
  • patients that undergo surgical aortic valve replacement for aortic stenosis
  • patients with contraindications for iodine contrast agent administration (acute renal failure, allergy, thyroid dysfunction).
  • other conditions associated with suboptimal CCTA image acquisition which could interfere with CT image postprocessing for creation of 3D printed models.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardio Med Medical Center

Târgu Mureş, 540124, Romania

RECRUITING

Related Publications (4)

  • Cernica D, Benedek I, Polexa S, Tolescu C, Benedek T. 3D Printing-A Cutting Edge Technology for Treating Post-Infarction Patients. Life (Basel). 2021 Sep 1;11(9):910. doi: 10.3390/life11090910.

    PMID: 34575059BACKGROUND
  • Benedek A, Cernica D, Mester A, Opincariu D, Hodas R, Rodean I, Keri J, Benedek T. Modern Concepts in Regenerative Therapy for Ischemic Stroke: From Stem Cells for Promoting Angiogenesis to 3D-Bioprinted Scaffolds Customized via Carotid Shear Stress Analysis. Int J Mol Sci. 2019 May 25;20(10):2574. doi: 10.3390/ijms20102574.

    PMID: 31130624BACKGROUND
  • Wang DD, Qian Z, Vukicevic M, Engelhardt S, Kheradvar A, Zhang C, Little SH, Verjans J, Comaniciu D, O'Neill WW, Vannan MA. 3D Printing, Computational Modeling, and Artificial Intelligence for Structural Heart Disease. JACC Cardiovasc Imaging. 2021 Jan;14(1):41-60. doi: 10.1016/j.jcmg.2019.12.022. Epub 2020 Aug 26.

    PMID: 32861647BACKGROUND
  • Vukicevic M, Mosadegh B, Min JK, Little SH. Cardiac 3D Printing and its Future Directions. JACC Cardiovasc Imaging. 2017 Feb;10(2):171-184. doi: 10.1016/j.jcmg.2016.12.001.

    PMID: 28183437BACKGROUND

MeSH Terms

Conditions

Aortic Valve StenosisAortic Valve Disease

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Study Officials

  • Daniel Cernica, MD

    CardioMed Medical Center

    STUDY DIRECTOR

Central Study Contacts

Theodora Benedek, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2022

First Posted

August 2, 2022

Study Start

July 8, 2022

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

May 16, 2023

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be available for interested parties.

Shared Documents
STUDY PROTOCOL
Time Frame
The IPD sharing frame is starting 6 months after publication.

Locations